HAVCR2 and neoplasm: Through interactions with its ligands, including galectin-9, carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), and phosphatidylserine, TIM-3 inhibits T-cell function, promotes immune tolerance, and ultimately facilitates tumor immune evasion.